# IMPACT EU Post-Market Clinical Follow-Up Study

> **NCT05756751** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Abiomed Inc.** · enrollment: 123 (actual)

## Conditions studied

- Left Ventricular Dysfunction

## Interventions

- **DEVICE:** Device: Impella 5.5 with SmartAssist

## Key facts

- **NCT ID:** NCT05756751
- **Lead sponsor:** Abiomed Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-04-27
- **Primary completion:** 2026-08-08
- **Final completion:** 2026-08-08
- **Target enrollment:** 123 (ACTUAL)
- **Last updated:** 2025-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05756751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05756751, "IMPACT EU Post-Market Clinical Follow-Up Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05756751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*